Hirano, Michio
Columbia University Irving Medical Center · Columbia University
17 papers on CoChatORCID 0000-0002-7070-7402
Most cited papers
- Verified
Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., et al. (2000) · Nature
Glycogen Storage Diseases and MyoclonusLysosomal Storage Disorders Research
Cited by 959
- Verified
Human mitochondrial DNA: roles of inherited and somatic mutations
Schon, E. A., DiMauro, S., & Hirano, M. (2012) · Nature Reviews Genetics
Mitochondrial Function and PathologyMetabolism and Genetic Disorders
Cited by 757
- Verified
Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial medicine society
Parikh, S., Goldstein, A., Koenig, M. K., Scaglia, F., Enns, G. M., Saneto, R., Anselm, I., Cohen, B. H., Falk, M. J., Greene, C., et al. (2015) · Genetics in Medicine
Mitochondrial Function and PathologyMetabolism and Genetic Disorders
Cited by 607
- Verified
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
Suomalainen, A., Elo, J. M., Pietiläinen, K. H., Hakonen, A. H., Sevastianova, K., Korpela, M., Isohanni, P., Marjavaara, S. K., Tyni, T., Kiuru-Enari, S., et al. (2011) · The Lancet Neurology
Metabolism and Genetic DisordersMitochondrial Function and Pathology
Cited by 427
- Verified
Early‐onset familial parkinsonism due to POLG mutations
Davidzon, G., Greene, P., Mancuso, M., Klos, K. J., Ahlskog, J. E., Hirano, M., & DiMauro, S. (2006) · Annals of Neurology
Parkinson's Disease Mechanisms and TreatmentsMitochondrial Function and Pathology
Cited by 239
- Verified · note
Heterogeneity of Coenzyme Q10Deficiency: Patient Study and Literature Review
Emmanuele, V., López, L. C., Berardo, A., Naini, A., Tadesse, S., Wen, B., D’Agostino, E., Solomon, M., DiMauro, S., Quinzii, C., et al. (2012) · Archives of Neurology
Coenzyme Q10 studies and effectsMetabolism and Genetic Disorders
Cited by 214
- Verified
A functionally dominant mitochondrial DNA mutation
Sacconi, S., Salviati, L., Nishigaki, Y., Walker, W. F., Hernandez-Rosa, E., Trevisson, E., Delplace, S., Desnuelle, C., Shanske, S., Hirano, M., et al. (2008) · Human Molecular Genetics
Mitochondrial Function and PathologyMetabolism and Genetic Disorders
Cited by 113
- Verified
Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA
Hirano, M., Marti, R., Ferreiro-Barros, C., Vilà, M. R., Tadesse, S., Nishigaki, Y., Nishino, I., & Vu, T. H. (2001) · Seminars in Cell & Developmental Biology
Mitochondrial Function and PathologyMetabolism and Genetic Disorders
Cited by 109
- Verified
Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes
Joseph, L. C., Barca, E., Subramanyam, P., Komrowski, M., Pajvani, U., Colecraft, H. M., Hirano, M., & Morrow, J. P. (2016) · PLOS ONE
Mitochondrial Function and PathologyCardiac Ischemia and Reperfusion
Cited by 99
- Verified
Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome
Siegmund, S. E., Yang, H., Sharma, R., Javors, M., Skinner, O., Mootha, V., Hirano, M., & Schon, E. A. (2017) · Human Molecular Genetics
Mitochondrial Function and PathologyGenetics, Aging, and Longevity in Model Organisms
Cited by 92
- Verified
Advancements in the pathophysiology of Friedreich’s Ataxia and new prospects for treatments
Babady, N. E., Carelle, N., Wells, R. D., Rouault, T. A., Hirano, M., Lynch, D. R., Delatycki, M. B., Wilson, R. B., Isaya, G., & Puccio, H. (2007) · Molecular Genetics and Metabolism
Genetic Neurodegenerative DiseasesHereditary Neurological Disorders
Cited by 73
- Verified
Human aging DNA methylation signatures are conserved but accelerated in cultured fibroblasts
Sturm, G., Cardenas, A., Bind, M.-A., Horvath, S., Wang, S., Wang, Y., Hägg, S., Hirano, M., & Picard, M. (2019) · Epigenetics
Epigenetics and DNA MethylationTelomeres, Telomerase, and Senescence
Cited by 61
- Verified
Nutritional interventions in primary mitochondrial disorders: Developing an evidence base
Camp, K. M., Krotoski, D., Parisi, M. A., Gwinn, K. A., Cohen, B. H., Cox, C. S., Enns, G. M., Falk, M. J., Goldstein, A. C., Gopal-Srivastava, R., et al. (2016) · Molecular Genetics and Metabolism
Metabolism and Genetic DisordersMitochondrial Function and Pathology
Cited by 59
- Verified
The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
Rodríguez Cruz, P. M., Cossins, J., de Paula Estephan, E., Munell, F., Selby, K., Hirano, M., Maroofin, R., Mehrjardi, M. Y. V., Chow, G., Carr, A., et al. (2019) · Brain
Myasthenia Gravis and ThymomaMuscle Physiology and Disorders
Cited by 51
- Verified
Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript
Alemi, M., Prigione, A., Wong, A., Schoenfeld, R., DiMauro, S., Hirano, M., Taroni, F., & Cortopassi, G. (2007) · Free Radical Biology and Medicine
Mitochondrial Function and PathologyAutophagy in Disease and Therapy
Cited by 50
- Verified
Hypermetabolism and energetic constraints in mitochondrial disorders
Sercel, A. J., Sturm, G., Gallagher, D., St-Onge, M.-P., Kempes, C. P., Pontzer, H., Hirano, M., & Picard, M. (2024) · Nature Metabolism
Mitochondrial Function and PathologyMetabolism and Genetic Disorders
Cited by 34
- Verified
Leber's hereditary optic neuropathy mitochondrial DNA mutations in normal-tension glaucoma
Opial, D., Boehnke, M., Tadesse, S., Lietz-Partzsch, A., Flammer, J., Munier, F., Mermoud, A., Hirano, M., Flückiger, F., & Mojon, D. S. (2001) · Graefe's Archive for Clinical and Experimental Ophthalmology
Glaucoma and retinal disordersMitochondrial Function and Pathology
Cited by 32
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free